» Articles » PMID: 12874262

The Early Progenitors of Mouse Dendritic Cells and Plasmacytoid Predendritic Cells Are Within the Bone Marrow Hemopoietic Precursors Expressing Flt3

Overview
Journal J Exp Med
Date 2003 Jul 23
PMID 12874262
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

Flt3 ligand (Flt3L) is a growth factor for hemopoietic progenitors and can promote the expansion of both conventional dendritic cells (DCs) and plasmacytoid predendritic cells (p-preDCs). The cells responding to Flt3L treatment and the precursors for the DCs and p-preDCs had not been fully characterized. We examined different mouse bone marrow (BM) hemopoietic precursor populations for the surface expression of Flt3 and tested them for early DC and p-preDC precursor activity. Most DC precursor activity, other than that given by multipotent hemopoietic stem cells, was within the downstream precursors expressing Flt3. The majority of mouse BM common lymphoid precursors expressed high levels of Flt3 and these were the most efficient precursors of both DCs and p-preDCs. In contrast, only a small proportion of the common myeloid precursors (CMPs) expressed Flt3, but the precursor activity for both DCs and p-preDCs was within this minor Flt3+ CMP fraction. The granulocyte and macrophage precursors and pro-B cells did not express Flt3 and had no DC or p-preDC precursor activity. These findings demonstrate that the early precursors for all DC subtypes are within the BM Flt3+ precursor populations, regardless of their lymphoid or myeloid lineage orientation.

Citing Articles

Advancing the understanding and management of blastic plasmacytoid dendritic cell neoplasm: Insights from recent case studies.

Luo Y, Wang L, Wang C World J Clin Cases. 2024; 12(31):6441-6446.

PMID: 39507120 PMC: 11438698. DOI: 10.12998/wjcc.v12.i31.6441.


Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling.

Monti M, Ferrari G, Gazzurelli L, Bugatti M, Facchetti F, Vermi W J Exp Clin Cancer Res. 2024; 43(1):196.

PMID: 39020402 PMC: 11253500. DOI: 10.1186/s13046-024-03121-9.


FLT3L-dependent dendritic cells control tumor immunity by modulating Treg and NK cell homeostasis.

Regnier P, Vetillard M, Bansard A, Pierre E, Li X, Cagnard N Cell Rep Med. 2023; 4(12):101256.

PMID: 38118422 PMC: 10772324. DOI: 10.1016/j.xcrm.2023.101256.


Regulation of pDC fate determination by histone deacetylase 3.

Zhang Y, Wu T, He Z, Lai W, Shen X, Lv J Elife. 2023; 12.

PMID: 38011375 PMC: 10732571. DOI: 10.7554/eLife.80477.


Guidelines for mouse and human DC generation.

Lutz M, Ali S, Audiger C, Autenrieth S, Berod L, Bigley V Eur J Immunol. 2022; 53(11):e2249816.

PMID: 36303448 PMC: 10704271. DOI: 10.1002/eji.202249816.


References
1.
Bruno L, Seidl T, Lanzavecchia A . Mouse pre-immunocytes as non-proliferating multipotent precursors of macrophages, interferon-producing cells, CD8alpha(+) and CD8alpha(-) dendritic cells. Eur J Immunol. 2001; 31(11):3403-12. DOI: 10.1002/1521-4141(200111)31:11<3403::aid-immu3403>3.0.co;2-t. View

2.
Akashi K, Traver D, Miyamoto T, Weissman I . A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000; 404(6774):193-7. DOI: 10.1038/35004599. View

3.
OKeeffe M, Hochrein H, Vremec D, Pooley J, Evans R, Woulfe S . Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood. 2002; 99(6):2122-30. DOI: 10.1182/blood.v99.6.2122. View

4.
Gilliet M, Boonstra A, Paturel C, Antonenko S, Xu X, Trinchieri G . The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med. 2002; 195(7):953-8. PMC: 2193725. DOI: 10.1084/jem.20020045. View

5.
Gilliland D, Griffin J . The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002; 100(5):1532-42. DOI: 10.1182/blood-2002-02-0492. View